• Mon, March 3, 2014
  • Wed, March 5, 2014
  • Thu, March 6, 2014
  • Tue, March 4, 2014
  • Fri, March 7, 2014
  • Mon, March 10, 2014
  • Tue, March 11, 2014
  • Mon, March 17, 2014
  • Fri, March 14, 2014
  • Wed, March 12, 2014

Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $56 on, Mar 3rd, 2014

Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $50 to $56 on, Mar 3rd, 2014.

Liav has made no other calls on TEVA in the last 4 months.



There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Liav's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


This is the rating of the analyst that currently disagrees with Liav


  • Chris Schott of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $38 on, Monday, November 4th, 2013